GGrantIndex
Sort

64,565 grants matching drug discovery

Identifying and targeting collateral lethal vulnerabilities in cancers

$918,686
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · U01 · FY2024 · CA

Small Molecule Inhibitors of Ebola Virus Polymerase Function

$918,430
Christopher F Basler · Georgia State University · R01 · FY2017 · AI

NRF Transcription Factors in Environmental Stress and Disease Intervention

$918,204
Donna D Zhang · University Of Arizona · R35 · FY2021 · ES

Design and Study of New Nicotinic Analogs for Use in Depression

$918,114
Alan P. Kozikowski · University Of Illinois At Chicago · U19 · FY2011 · MH

CANCER DRUG DISCOVERY: CELL CYCLE CONTROL TARGETS

$918,099
University Of South Florida · P01 · FY2002 · CA

CI-TEAM Implementation for Biological Researchers, Educators, and Developers (CIBRED)

$918,000
Stephen Cammer · Virginia Polytechnic Institute And State University · · FY2008 · CSE

Identifying Genetic Variants Associated with Opioid Overdose Mortality

$917,989
Elliot C Nelson · Washington University · R01 · FY2020 · DA

Rapid Kinase Profiling with Luminescent Reporters

$917,931
Reena Zutshi · Luceome Biotechnologies, Llc · R44 · FY2011 · GM

Mechanistic studies of chromatin modification in transcription regulation

$917,920
Cynthia Wolberger · Johns Hopkins University · R35 · FY2025 · GM

India International Center for Excellence in Research

$917,866
Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer

$917,850
Robert C Bast · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA

The Neuroproteomics and Neurometabolomics Center on Cell-Cell Signaling

$917,843
Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2018 · DA

The Neuroproteomics and Neurometabolomics Center on Cell-Cell Signaling

$917,843
Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2017 · DA

Specificity Screening Drug Development Tool for Biotherapeutic Safety

$917,454
Benjamin Jacob Doranz · Integral Molecular · SB1 · FY2024 · GM

Research Infrastructure Core

$917,421
Renato J Aguilera · University Of Texas El Paso · U54 · FY2021 · MD

High throughput tau oligomer assay for drug screening for Alzheimer's disease

$917,397
James G. Moe · Oligomerix, Inc · R44 · FY2010 · AG

Tissue Processing-Sequencing Facility

$917,291
Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA

Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis

$917,279
Marc L Peters-Golden · University Of Michigan At Ann Arbor · R35 · FY2024 · HL

Translating novel cancer targets and mechanisms from the CTD^2 Network using molecular glues

$917,278
Stuart L Schreiber · Broad Institute, Inc. · U01 · FY2023 · CA

Centenarian Consortium Project

$917,118
Thomas T Perls · California Pacific Med Ctr Res Institute · U19 · FY2020 · AG

Countermeasures Against Chemical Threats ^ Preclinical Development Facility

$917,058
Carol E Green · Sri International · N01 · FY2016 · NS

Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma

$916,726
Frank D. McKeon · University Of Houston · R01 · FY2023 · CA

Chemical Proteomic Platforms for Radically Expanding Cancer Druggability

$916,320
Benjamin F Cravatt · Scripps Research Institute, The · R35 · FY2025 · CA

Attacking stress tolerance in cancer

$916,317
David A Cheresh · University Of California, San Diego · R35 · FY2019 · CA

NATURAL PRODUCTS DISCOVERY - NUCLEAR AND SIGNALING TARGE

$916,274
University Of Virginia Charlottesville · U19 · FY2002 · CA